Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

about

The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity.

P2860

Q46249649-AB92DE87-6686-4A41-AC18-C59B05CB3498

P2860

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

Item

http://www.wikidata.org/entity/Q40710330

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

@en

type

Item

label

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

@en

prefLabel

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

@en

P1476

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

@en

P2093

Bicky Vettichira

http://www.w3.org/2001/XMLSchema#string

Jennifer Chee

http://www.w3.org/2001/XMLSchema#string

Kemar Brown

http://www.w3.org/2001/XMLSchema#string

Lampros Papadimitriou

http://www.w3.org/2001/XMLSchema#string

Stella Kyung

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure.

Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Spironolactone for heart failure with preserved ejection fraction.

Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial.

P2888

s11936-015-0402-1

P304

402

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11936-015-0402-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Javed Butler

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1033302954

http://www.w3.org/2001/XMLSchema#string

P698

26199117

http://www.w3.org/2001/XMLSchema#string

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

about

P2860

P2860

Mineralocorticoid Receptor Antagonism in Acute Heart Failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698